Selective inhibition of the hypoxia-inducible factor prolyl hydroxylase PHD3 by Zn(II)

被引：2
|
作者：
Na, Yu-Ran [1 ,2 ]
Woo, Dustin J. [1 ,3 ]
Choo, Hyunah [3 ,4 ]
Chung, Hak Suk [1 ,3 ]
Yang, Eun Gyeong [1 ,3 ]
机构：
[1] Korea Inst Sci & Technol, Biomed Res Inst, Ctr Theragnosis, Seoul 136791, South Korea
[2] Korea Univ, Res Inst Nat Sci, Dept Chem, Seoul 136701, South Korea
[3] Korea Univ Sci & Technol UST, Dept Biol Chem, Seoul 136791, South Korea
[4] Korea Inst Sci & Technol, Ctr Neuromed, Brain Sci Inst, Seoul 136791, South Korea
来源：
CHEMICAL COMMUNICATIONS | 2015年 / 51卷 / 53期
关键词：
ERYTHROPOIETIN GENE; HIF-ALPHA; FACTOR-I; BINDING; DESFERRIOXAMINE; COPPER;
D O I：
10.1039/c5cc02143j
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
We report herein that Zn(II) selectively inhibits the hypoxia- inducible factor prolyl hydroxylase PHD3 over PHD2, and does not compete with Fe(II). Independent of the oligomer formation induced by Zn(II), inhibition of the activity of PHD3 by Zn(II) involves Cys42 and Cys52 residues distantly located from the active site.
引用
收藏
页码：10730 / 10733
页数：4
相关论文
共 50 条
  • [31] Hypoxia-inducible factor prolyl hydroxylase inhibition: robust new target or another big bust for stroke therapeutics?
    Karuppagounder, Saravanan S.
    Ratan, Rajiv R.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 (07): : 1347 - 1361
  • [32] Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Treatment of Post Kidney Transplant Anemia
    Ogata, Masatomo
    Miyauchi, Takamasa
    Murata, Marie
    Terashita, Maho
    Osako, Kiyomi
    Shinoda, Kazunobu
    Shibagaki, Yugo
    Yazawa, Masahiko
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 552 - 552
  • [33] Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
    Moslehi, Javid
    Minamishima, Yoji Andrew
    Shi, Jianru
    Neuberg, Donna
    Charytan, David M.
    Padera, Robert F.
    Signoretti, Sabina
    Liao, Ronglih
    Kaelin, William G., Jr.
    CIRCULATION, 2010, 122 (10) : 1004 - U108
  • [34] The prolyl hydroxylase enzymes that act as oxygen sensors regulating destruction of hypoxia-inducible factor α
    Willam, C
    Nicholls, LG
    Ratcliffe, PJ
    Pugh, CW
    Maxwell, PH
    ADVANCES IN ENZYME REGULATION, VOL 44, 2004, 44 : 75 - 92
  • [35] Activation of the hypoxia-inducible factor pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors
    Warnecke, C
    Griethe, W
    Weidemann, A
    Jürgensen, JS
    Willam, C
    Bachmann, S
    Ivashchenko, Y
    Wagner, I
    Frei, U
    Wiesener, M
    Eckardt, KU
    FASEB JOURNAL, 2003, 17 (06): : 1186 - +
  • [36] Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors and Hypothyroidism: An Analysis of the Japanese Pharmacovigilance Database
    Tanaka, Hiroyuki
    Tani, Alicia
    Onoda, Toshihisa
    Ishii, Toshihiro
    IN VIVO, 2024, 38 (02): : 917 - 922
  • [37] Studies on the Substrate Selectivity of the Hypoxia-Inducible Factor Prolyl Hydroxylase 2 Catalytic Domain
    Abboud, Martine I.
    Chowdhury, Rasheduzzaman
    Leung, Ivanhoe K. H.
    Lippl, Kerstin
    Loenarz, Christoph
    Claridge, Timothy D. W.
    Schofield, Christopher J.
    CHEMBIOCHEM, 2018, 19 (21) : 2262 - 2267
  • [38] Updates on hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of renal anemia
    Li, Jing
    Haase, Volker H. H.
    Hao, Chuan-Ming
    KIDNEY DISEASES, 2023, 9 (01) : 1 - 11
  • [39] Hypoxia-inducible factor?prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease
    Haase, Volker H.
    KIDNEY INTERNATIONAL SUPPLEMENTS, 2021, 11 (01) : 8 - 25
  • [40] Hypoxia-inducible factor prolyl hydroxylase inhibitor in the treatment of anemia in chronic kidney disease
    Kurata, Yu
    Tanaka, Tetsuhiro
    Nangaku, Masaomi
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2020, 29 (04): : 414 - 422
12345